Make your own drugs, UN Aids chief urges AfricaBy CHIBAULA D SILWAMBA | Thursday, May 17  2012 at  11:19

An undated photo of UNAIDS executive director Michel Sidibe. The UN under-secretary-general has urged African nations to reduce their dependence on external funding for HIV\Aids treatment. FILE 

A UN under-secretary-general has urged African nations to look to raising funds locally for the treatment of HIV treatment and strategise on making antiretroviral drugs within the continent.

Briefing African diplomats accredited to the United Nations at the African Union offices in New York, UNAIDS executive director Michel Sidibé said the continent had in the last ten years made impressive progress in combating HIV/Aids.

The briefing was themed Recent developments in the AIDS response with a focus on the impact of the financial crisis and Africa's dependence on external funding.

Mr Sidibé, a Malian national, urged Africans to sustain the gains made so far. He however noted that between 80 and 90 per cent, and in some countries 100 per cent, of people on HIV treatment relied on external resources mostly from the Global Fund and US President's Emergency Plan for Aids Relief (PEPFAR).

New approach

"This is a major challenge for us," he said. "I want your help (as ambassadors). We want to organise a side event with African Presidents during the next UN General Assembly to start the discussion about the ownership of how we can have a new approach of financing global health by making Africa drive this discussion."

Mr Sidibé expressed concern that almost 25 to 30 per cent of the medicines on the market nowadays were counterfeit.

He further explained that between 90 and 95 per cent of medicines consumed in Africa were manufactured abroad particularly in Asia.

"But we now need to start thinking about manufacturing medicines in Africa," Mr Sidibé said. "I have been privileged to address the (New Partnership for Africa's Development) NEPAD heads of state and they asked us to come up with the road map on sustainable financing and mobilising additional resources internally in Africa for drugs and treatment."

Mr Sidibé said most African countries had already increased their domestic budgetary allocation to HIV/Aids reduced prices of medicines and increased the number of recipients of drugs.

"We know that we managed to change the trajectory of this epidemic on the continent but we still have nine million people today waiting for treatment," the UNAIDS chief said.

"The problem we will be facing soon is that most of our people are on first line treatment, which means they are relying on treatment which is not used in the rest of the world.

"We need to be ready with our six million people who are on treatment moving from first line to second line or even third line treatment but it means you have to multiply the cost of treatment by almost 10 (times)."

'More efficient'

According to Mr Sidibé, almost 1.8 million people die from HIV/Aids in Africa annually and said Aids was "still an emergency issue" in Africa.

"We need to continue to push to make sure that access to treatment is a reality for our continent," said Mr Sidibé, adding that science had shown that putting people on HIV treatment early reduces infection by 96 per cent meaning that "early treatment is more efficient than condoms".

He explained that almost 400, 000 babies were born with HIV in Africa and "we can stop that".

"We need to make sure that we don't have babies born with HIV," said Mr Sidibé.

African diplomats pledged their support to combat HIV/Aids and their Governments' commitment to mobilise local resources.

--The Author is First Secretary for Press Permanent Mission of the Republic of Zambia to the United Nations based in New York